Citation: | WU Feng, SONG Tingting, ZANG Xiao, HONG Shanchao, WANG Wei. miR-142-3p alleviates house dust mite-induced airway inflammation among children[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2023, 44(12): 1883-1888. doi: 10.16835/j.cnki.1000-9817.2023.12.026 |
[1] |
HOLGATE S T, WENZEL S, POSTMA D S, et al. Asthma[J]. Nat Rev Dis Primers, 2015, 1(1): 15025. doi: 10.1038/nrdp.2015.25
|
[2] |
HUANG K, YANG T, XU J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study[J]. Lancet, 2019, 394(10196): 407-418. doi: 10.1016/S0140-6736(19)31147-X
|
[3] |
KANAGARATHAM C, RADZIOCH D. Allergic asthma: a summary from genetic basis, mouse studies, to diagnosis and treatment[J]. Curr Pharm Des, 2016, 22(41): 6261-6272. doi: 10.2174/1381612822666160829141708
|
[4] |
THOMAS W R, HALES B J, SMITH W A. House dust mite allergens in asthma and allergy[J]. Trends Mol Med, 2010, 16(7): 321-328. doi: 10.1016/j.molmed.2010.04.008
|
[5] |
SHIPP C L, GERGEN P J, GERN J E, et al. Asthma management in children[J]. J Allergy Clin Immunol Pract, 2023, 11(1): 9-18. doi: 10.1016/j.jaip.2022.10.031
|
[6] |
GAN H, LUO W, HUANG Z, et al. House dust mite components sensitization profile in China, a multi-centre study[J]. Clin Exp Allergy, 2023, 53(2): 226-229. doi: 10.1111/cea.14255
|
[7] |
SALIMINEJAD K, KHORRAM KHORSHID H R, SOLEYMANI FA-RD S, et al. An overview of microRNAs: biology, functions, therapeutics, and analysis methods[J]. J Cell Physiol, 2019, 234(5): 5451-5465. doi: 10.1002/jcp.27486
|
[8] |
WANG X, GUO Y, WANG C, et al. microRNA-142-3p inhibits cho-ndrocyte apoptosis and inflammation in osteoarthritis by targeting HMGB1[J]. Inflammation, 2016, 39(5): 1718-1728. doi: 10.1007/s10753-016-0406-3
|
[9] |
WANG Y, LIANG J, QIN H, et al. Elevated expression of miR-142-3p is related to the pro-inflammatory function of monocyte-derived dendritic cells in SLE[J]. Arthritis Res Ther, 2016, 18(1): 263. doi: 10.1186/s13075-016-1158-z
|
[10] |
WU M, HUANG Z, HUANG W, et al. microRNA-124-3p attenuates myocardial injury in sepsis via modulating SP1/HDAC4/HIF-1α axis[J]. Cell Death Discov, 2022, 8(1): 40. doi: 10.1038/s41420-021-00763-y
|
[11] |
GUIOT J, CAMBIER M, BOECKX A, et al. Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p[J]. Thorax, 2020, 75(10): 870-881. doi: 10.1136/thoraxjnl-2019-214077
|
[12] |
KLEINJAN A. Airway inflammation in asthma: key players beyond the Th2 pathway[J]. Curr Opin Pulm Med, 2016, 22(1): 46-52. doi: 10.1097/MCP.0000000000000224
|
[13] |
DAVIS J D, WYPYCH T P. Cellular and functional heterogeneity of the airway epithelium[J]. Mucosal Immunol, 2021, 14(5): 978-990. doi: 10.1038/s41385-020-00370-7
|
[14] |
LIVAK K J, SCHMITTGEN T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C(T)] Method[J]. Methods, 2001, 25(4): 402-408. doi: 10.1006/meth.2001.1262
|
[15] |
BEREDA G. Bronchial asthma: etiology, pathophysiology, diagnosis and management[J]. Austin J Pulm Respir Med, 2022, 9(1): 1085.
|
[16] |
LI X, SONG P, ZHU Y, et al. The disease burden of childhood asthma in China: a systematic review and Meta-analysis[J]. J Glob Health, 2020, 10(1): 010801. doi: 10.7189/jogh.10.010801
|
[17] |
MAUER Y, TALIERCIO R M. Managing adult asthma: the 2019 GINA guidelines[J]. Cleve Clin J Med, 2020, 87(9): 569-575. doi: 10.3949/ccjm.87a.19136
|
[18] |
SIMONEAU T, CLOUTIER M M. Controversies in pediatric asthma[J]. Pediatr Ann, 2019, 48(3): e128-e134.
|
[19] |
WEIDNER J, BARTEL S, KILIÇ A, et al. Spotlight on microRNAs in allergy and asthma[J]. Allergy, 2021, 76(6): 1661-1678. doi: 10.1111/all.14646
|
[20] |
QING X, ZHANG Y, PENG Y, et al. Mir-142-3p regulates inflammatory response by contributing to increased TNF-α in chronic rhinosinusitis with nasal polyposis[J]. Ear Nose Throat J, 2021, 100(1): NP50-NP56. doi: 10.1177/0145561319847972
|
[21] |
BARTEL S, CARRARO G, ALESSANDRINI F, et al. miR-142-3p is associated with aberrant WNT signaling during airway remodeling in asthma[J]. Am J Physiol Lung Cell Mol Physiol, 2018, 315(2): L328-L333. doi: 10.1152/ajplung.00113.2018
|
[22] |
WANG J Y, DONG X, YU Z, et al. Borneol inhibits CD4+ T cells proliferation by down-regulating miR-26a and miR-142-3p to attenuate asthma[J]. Int Immunopharmacol, 2021, 90: 107223. doi: 10.1016/j.intimp.2020.107223
|
[23] |
DUMITRIU I E, BARUAH P, MANFREDI A A, et al. HMGB1: an immmune odyssey[J]. Discov Med, 2005, 5(28): 388-392.
|
[24] |
ZHAO Y, LI R. HMGB1 is a promising therapeutic target for asthma[J]. Cytokine, 2023, 165: 156171. doi: 10.1016/j.cyto.2023.156171
|
[25] |
KO H K, HSU W H, HSIEH C C, et al. High expression of high-mobility group box 1 in the blood and lungs is associated with the development of chronic obstructive pulmonary disease in smokers[J]. Respirology, 2014, 19(2): 253-261. doi: 10.1111/resp.12209
|
[26] |
CHENG Y, WANG D, WANG B, et al. HMGB1 translocation and release mediate cigarette smoke-induced pulmonary inflammation in mice through a TLR4/MyD88-dependent signaling pathway[J]. Mol Biol Cell, 2017, 28(1): 201-209. doi: 10.1091/mbc.e16-02-0126
|
[27] |
HUANG W F, ZHAO H J, DONG H M, et al. High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway[J]. Int J Mol Med, 2016, 37(5): 1189-1198. doi: 10.3892/ijmm.2016.2537
|